Skip to main content

MGC Pharmaceuticals' proprietary ZAM app "about good practice"

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Proactive's Thomas Warner after announcing the enrolment of the first patient in its proprietary data collection App and machine learning algorithm, ZAM.

Clements explains why MGC is investing in medical technology, saying that "this is about good practice."

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.56
-5.56 (-2.64%)
AAPL  266.55
+1.97 (0.74%)
AMD  194.84
-5.31 (-2.65%)
BAC  51.24
-1.82 (-3.43%)
GOOG  311.26
-3.64 (-1.16%)
META  637.37
-18.29 (-2.79%)
MSFT  383.38
-13.85 (-3.49%)
NVDA  190.68
+0.86 (0.45%)
ORCL  140.04
-8.04 (-5.43%)
TSLA  395.06
-16.76 (-4.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.